Brief: Astrazeneca Pharma India Sept-Quarter PAT 542.2 Million Rupees
07/11/2025 12:24
Nov 7 (Reuters) - Astrazeneca Pharma India ASTR.NS: SEPT-QUARTER PAT 542.2 MILLION RUPEES SEPT-QUARTER REVENUE FROM OPERATIONS 5.59 BILLION RUPEES Source text: [ID:] Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan